mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-09 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-09 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-08 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |